IXICO plc (AIM: IXI) – strong interim results from the brain health company
IXICO plc, the brain health company, today announced its interim results for the six months ended 31 March 2015, showing strong progress in the period.
IXICO brings innovative technologies to those involved in researching and treating serious diseases, enabling them to help patients quicker. Their business has three core sections. The first being in clinical trials where they offer digital tools to support decision making and analysis. This section of the business brings in the highest revenue at present.
The second area of the business is in experimental medicine where IXICO work with pharmaceutical companies to research new tools…
Previous article Next article
